These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28324494)

  • 1. Analysis of Average Telomere Length in Human Telomeric Protein Knockout Cells Generated by CRISPR/Cas9.
    Xu J; Songyang Z; Liu D; Kim H
    Methods Mol Biol; 2017; 1587():15-28. PubMed ID: 28324494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of average telomere length in cultured human cells.
    Liu D
    Methods Mol Biol; 2011; 735():13-9. PubMed ID: 21461807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in therapeutic CRISPR/Cas9 genome editing.
    Savić N; Schwank G
    Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live Cell Imaging Reveals the Dynamics of Telomerase Recruitment to Telomeres.
    Schmidt JC; Zaug AJ; Cech TR
    Cell; 2016 Aug; 166(5):1188-1197.e9. PubMed ID: 27523609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology.
    Brane AC; Tollefsbol TO
    Cells; 2019 Feb; 8(2):. PubMed ID: 30795542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structure and function of CRISPR-Cas9].
    Nishimasu H
    Seikagaku; 2015 Dec; 87(6):686-92. PubMed ID: 26863746
    [No Abstract]   [Full Text] [Related]  

  • 8. A Model to Investigate Single-Strand DNA Responses in G1 Human Cells via a Telomere-Targeted, Nuclease-Deficient CRISPR-Cas9 System.
    Crefcoeur RP; Zgheib O; Halazonetis TD
    PLoS One; 2017; 12(1):e0169126. PubMed ID: 28046023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging genomic elements in living cells using CRISPR/Cas9.
    Chen B; Huang B
    Methods Enzymol; 2014; 546():337-54. PubMed ID: 25398348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas: A New Tool in the Research of Telomeres and Telomerase as Well as a Novel Form of Cancer Therapy.
    Porika M; Tippani R; Saretzki GC
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of genome editing in studying hearing loss.
    Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
    Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and therapy with CRISPR advanced CRISPR based tools for point of care diagnostics and early therapies.
    Uppada V; Gokara M; Rasineni GK
    Gene; 2018 May; 656():22-29. PubMed ID: 29496558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome modification by CRISPR/Cas9.
    Ma Y; Zhang L; Huang X
    FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of CRISPR/Cas9 genome editing technology in cancer research].
    Wang DY; Ma N; Hui Y; Gao X
    Yi Chuan; 2016 Jan; 38(1):1-8. PubMed ID: 26787518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis and Genome Engineering of Epstein-Barr Virus in Cultured Human Cells by CRISPR/Cas9.
    Yuen KS; Chan CP; Kok KH; Jin DY
    Methods Mol Biol; 2017; 1498():23-31. PubMed ID: 27709566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres.
    Benetti R; García-Cao M; Blasco MA
    Nat Genet; 2007 Feb; 39(2):243-50. PubMed ID: 17237781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas systems for genome engineering and investigation.
    Concordet JP; Giovannangeli C
    Methods; 2017 May; 121-122():1-2. PubMed ID: 28645537
    [No Abstract]   [Full Text] [Related]  

  • 20. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
    Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
    Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.